Carregant...
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders
Muscarinic acetylcholine receptors (mAChRs) have long been viewed as viable targets for novel therapeutic agents for the treatment of Alzheimer’s disease (AD) and other disorders involving impaired cognitive function. More recent evidence indicates that mAChR activators might also have utility in tr...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2907736/ https://ncbi.nlm.nih.gov/pubmed/19201489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2008.12.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|